fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Thyrocare Technologies Ltd

Thyrocare Technologies Ltd

Updated on October 15, 2020

Stock/Share Code - THYROCARE

Thyrocare Technologies primarily operates in healthcare segment and is primarily involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Below is the details of THYROCARE Thyrocare Technologies Ltd

Market Cap₹3,966 Cr.
Current Price ₹1,097.4 as on 21 Oct 20
52 Week High / Low Price₹846.9 / ₹409.6
Face Value₹10
Stock P/E44.91
Book Value₹71.59
Dividend Yield0.67 %
ROCE37.39 %
ROE25.59 %
Sales Growth (3yrs)10.37 %
SectorHealthcare
IndustryHealthcare
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 66.71%
Cons: Stock is trading at 10.48 times its book value

Thyrocare Technologies Ltd Price Chart

Thyrocare Technologies Ltd Price Chart

Thyrocare Technologies Ltd Peer Comparison in Healthcare

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Apollo Hospitals ₹109.15 70.06 ₹22,740.7 Cr. 0.37 ₹219.36 Cr. -10.77 16.92 2922.43 14.55
2. Dr Lal Pathlabs ₹2,189 75.66 ₹14,792.47 Cr. 0.68 ₹28.4 Cr. -51.70 -20.64 266.00 32.08
3. Fortis Health. ₹126.9 ₹10,025.84 Cr. 0.00 -₹178.92 Cr. -407.61 -46.77 605.95 4.54
4. Max Healthcare ₹1.6 100.74 ₹9,624.23 Cr. 0.00 Cr.
5. Metropolis Healt ₹1,888.25 85.87 ₹9,318.58 Cr. 0.43 ₹2.9 Cr. -90.79 -29.60 143.13 40.06
6. Narayana Hrudaya ₹334.8 ₹6,611.07 Cr. 0.31 -₹119.71 Cr. -495.74 -49.38 393.50 13.22
7. Aster DM Health. ₹137.8 31.16 ₹6,511.15 Cr. 0.00 -₹82.93 Cr. -2643.87 -13.21 1760.63 12.98
8. Thyrocare Tech. 44.91 ₹3,965.9 Cr. 0.67 ₹4.42 Cr. -85.32 -45.87 54.40 37.39

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Thyrocare Technologies Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -81.7977.8490.0389.1995.6888.1297.29100.50107.8997.9993.6254.40
YOY Sales Growth %5.48%12.23%9.31%8.58%16.98%13.21%8.06%12.68%12.76%11.20%-3.77%-45.87%
Expenses -47.8344.0654.6249.9754.8654.1263.1956.4857.1755.3864.2444.89
Material Cost %30.47%25.35%27.76%27.45%28.51%27.67%29.99%29.37%27.80%26.95%28.21%47.10%
Employee Cost %8.03%11.16%11.61%9.22%9.67%11.16%13.58%10.61%9.82%11.89%13.73%16.53%
Operating Profit33.9633.7835.4139.2240.8234.0034.1044.0250.7242.6129.389.51
OPM %41.52%43.40%39.33%43.97%42.66%38.58%35.05%43.80%47.01%43.48%31.38%17.48%
Other Income3.014.1111.552.983.254.383.053.353.361.30-41.861.49
Interest0.090.100.120.110.120.120.120.320.470.260.270.20
Depreciation2.933.103.323.163.523.843.954.095.184.755.524.48
Profit before tax33.9534.6943.5238.9340.4334.4233.0842.9648.4338.90-18.276.32
Tax %30.96%37.30%36.44%34.81%34.41%34.81%36.85%29.93%22.71%23.11%0.99%30.06%
Net Profit23.4421.7527.6625.3826.5222.4420.8930.1037.4329.91-18.094.42
EPS in Rs4.364.085.154.724.944.253.925.707.225.66-3.430.84
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -5878109134150180235298332370400354
Sales Growth %33.50%40.08%23.08%11.71%20.07%30.58%26.53%11.51%11.60%8.03%
Expenses -3142607181105140182195222233222
Material Cost %35.68%30.10%26.65%26.51%28.34%30.67%28.49%26.20%27.38%28.44%28.08%
Manufacturing Cost %1.03%1.73%2.78%2.59%4.17%7.77%11.15%11.39%7.10%7.18%0.00%
Employee Cost %6.75%6.82%6.53%6.73%8.06%9.42%10.33%10.16%9.79%10.94%11.44%
Other Cost %8.93%15.54%19.04%16.83%13.53%10.67%9.57%13.49%14.49%13.43%18.80%
Operating Profit28364964697595115137148167132
OPM %48%46%45%47%46%41%40%39%41%40%42%37%
Other Income73518796-162414-34-36
Interest000000100011
Depreciation1123611111212142020
Profit before tax333852786973898714814711275
Tax %30%34%33%27%33%33%34%46%35%35%29%
Net Profit232535574649594796957954
EPS in Rs18.3022.9732.3352.0442.289.7510.948.6917.8818.0415.0210.29
Dividend Payout %88%0%0%0%0%157%91%115%56%111%33%

Compounded Sales Growth

  • 10 Years:: 21.23%
  • 5 Years:: 17.31%
  • 3 Years:: 10.37%
  • TTM:: -7.26%

Compounded Profit Growth

  • 10 Years:: 18.93%
  • 5 Years:: 17.81%
  • 3 Years:: 20.11%
  • TTM:: -11.66%

Return on Equity

  • 3 Years:: 3.21%
  • 1 Year:: 61.62%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -1111111111515454545353
Equity Capital1111111111515454545353
Reserves315792149195229322364400403325
Borrowings025252525000009
Other Liabilities -308101114143926313255
Trade Payables3.293.540.560.211.510.821.450.875.695.3719.17
Advance from Customers2.480.171.041.551.831.241.682.630.000.00
Other liability items24.284.708.009.6611.1212.0035.9522.6625.7926.7035.79
Total Liabilities72101137197246293414444485488442
Fixed Assets -1516207587839389103108112
Gross Block21242986105110131101126145
Accumulated Depreciation67911172738122337
CWIP000106612014
Investments0242477119162266299315289239
Other Assets -5761933433425554688988
Inventories2.494.005.105.256.307.059.8913.7616.4715.5618.49
Trade receivables1.792.963.433.334.914.657.305.989.2111.0615.19
Cash Equivalents8.4740.0459.0317.5311.904.297.6510.629.289.057.30
Loans n Advances44.349.0922.492.344.2621.4724.5021.285.745.0521.91
Other asset items-0.064.453.405.395.594.795.402.3326.9348.2824.70
Total Assets72101137197246293414444485488442

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -323137464636678911296136
Profit from operations28365064717599124148156172
Receivables-0-1-00-20-31-3-2-6
Inventory1-2-1-0-1-1-3-4-31-3
Payables-11-3-01-11-10-014
Loans Advances111043-2-17-2-514-1-0
Other WC items4-04222614354
Working capital changes15845-1-16-151128
Direct taxes-11-14-17-23-23-23-31-40-48-61-44
Cash from Investing Activity -11-24-18-88-52-21-19-40-48-327
Fixed assets purchased-3-5-5-69-15-16-15-11-25-20-142
Fixed assets sold9302001200010
Investments purchased-8-240-94-307-182-100-120-91-1120
Investments sold100033268160948998141143
Interest received22440000133
Dividends received00001524410
Loans to subsidiaries00000000-24-1423
Acquisition of companies00000000-1000
Other investing items00-171610-0-2-0-3-0
Cash from Financing Activity --3825010-23-45-48-65-96-163
Proceeds from shares025010000000
Interest paid fin-210000000000
Dividends paid-00000-19-38-40-54-27-132
Financial liabilities0000000000-7
Other financing items-180000-4-7-8-11-69-23
Net Cash Flow53219-42-6-731-1-31

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %55%47%50%33%27%27%29%33%31%37%
Debtor Days1114119129117101114
Inventory Turnover7.476.847.257.818.818.356.996.336.936.60

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Thyrocare Technologies Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.